Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adults patients with rheumatoid arthritis
Patients who have received stable weekly doses of oral methotrexate (5 to 25 mg/week administered as a single dose) for a minimum of 28 days (4 weeks/4 doses)
You may not be if
History of chronic infectious disease such as genitourinary, pulmonary or sinus infections.
Any current or known malignancy or history of malignancy within the previous 5 years
Pregnant or lactating women; women of child-bearing potential who are unwilling to unable to use an acceptable method of birth control during the study
Clareo Health | Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis
